Annual Shareholders Equity
$438.84 M
+$42.69 M+10.78%
December 31, 2023
Summary
- As of February 8, 2025, KNSA annual stockholders equity is $438.84 million, with the most recent change of +$42.69 million (+10.78%) on December 31, 2023.
- During the last 3 years, KNSA annual shareholders equity has risen by +$126.90 million (+40.68%).
- KNSA annual shareholders equity is now at all-time high.
Performance
KNSA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$437.01 M
+$1.91 M+0.44%
September 30, 2024
Summary
- As of February 8, 2025, KNSA quarterly stockholders equity is $437.01 million, with the most recent change of +$1.91 million (+0.44%) on September 30, 2024.
- Over the past year, KNSA quarterly shareholders equity has increased by +$31.88 million (+7.87%).
- KNSA quarterly shareholders equity is now -0.42% below its all-time high of $438.84 million, reached on December 31, 2023.
Performance
KNSA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
KNSA Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +10.8% | +7.9% |
3 y3 years | +40.7% | +104.2% |
5 y5 years | +57.1% | +73.5% |
KNSA Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +137.2% | -0.4% | +184.7% |
5 y | 5-year | at high | +137.2% | -0.4% | +184.7% |
alltime | all time | at high | +589.2% | -0.4% | +587.1% |
Kiniksa Pharmaceuticals Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $437.01 M(+0.4%) |
Jun 2024 | - | $435.10 M(+0.7%) |
Mar 2024 | - | $431.89 M(-1.6%) |
Dec 2023 | $438.84 M(+10.8%) | $438.84 M(+8.3%) |
Sep 2023 | - | $405.13 M(-1.6%) |
Jun 2023 | - | $411.66 M(+5.5%) |
Mar 2023 | - | $390.10 M(-1.5%) |
Dec 2022 | $396.15 M(+114.1%) | $396.15 M(+3.2%) |
Sep 2022 | - | $384.01 M(+150.2%) |
Jun 2022 | - | $153.49 M(-7.7%) |
Mar 2022 | - | $166.24 M(-10.2%) |
Dec 2021 | $185.04 M | $185.04 M(-13.6%) |
Sep 2021 | - | $214.05 M(-9.2%) |
Jun 2021 | - | $235.78 M(-12.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $270.70 M(-13.2%) |
Dec 2020 | $311.94 M(+38.4%) | $311.94 M(-13.0%) |
Sep 2020 | - | $358.51 M(+43.2%) |
Jun 2020 | - | $250.42 M(+21.7%) |
Mar 2020 | - | $205.83 M(-8.7%) |
Dec 2019 | $225.42 M(-19.3%) | $225.42 M(-10.5%) |
Sep 2019 | - | $251.91 M(-8.5%) |
Jun 2019 | - | $275.20 M(-10.2%) |
Mar 2019 | - | $306.52 M(+9.8%) |
Dec 2018 | $279.27 M(-411.3%) | $279.27 M(-12.4%) |
Sep 2018 | - | $318.91 M(-6.7%) |
Jun 2018 | - | $341.80 M(+66.3%) |
Mar 2018 | - | $205.48 M(-329.1%) |
Dec 2017 | -$89.71 M(+248.6%) | -$89.71 M |
Dec 2016 | -$25.73 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual shareholders equity year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Kiniksa Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of KNSA is $438.84 M
What is the all time high annual shareholders equity for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual stockholders equity is $438.84 M
What is Kiniksa Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, KNSA annual stockholders equity has changed by +$42.69 M (+10.78%)
What is Kiniksa Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of KNSA is $437.01 M
What is the all time high quarterly shareholders equity for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly stockholders equity is $438.84 M
What is Kiniksa Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, KNSA quarterly stockholders equity has changed by +$31.88 M (+7.87%)